S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
SWOG Cancer Research Network
SWOG Cancer Research Network
Wake Forest University Health Sciences
GlaxoSmithKline
Alliance for Clinical Trials in Oncology
OHSU Knight Cancer Institute
Beth Israel Medical Center
University of South Florida